MRI — The Imaging Machine That Detects Cancer Without Radiation
Raymond Damadian's 1974 patent describes using nuclear magnetic resonance to distinguish cancerous tissue from healthy tissue — the foundational discovery that launched MRI scanning, though Damadian controversially did not share the Nobel Prize.
Original patent title: “Apparatus and method for detecting cancer in tissue”
What this patent covers
The actual claim
This patent describes a method of using nuclear magnetic resonance (NMR) to detect differences between cancerous and healthy tissue. NMR works by placing tissue in a strong magnetic field and then applying radio frequency pulses. The hydrogen nuclei (protons) in water and fat molecules absorb the radio energy and emit their own signals as they relax back to their baseline state. The key discovery: cancerous tissues have higher water content and different molecular environments than healthy tissues, causing their protons to relax differently — with longer T1 and T2 relaxation times. By measuring these relaxation times, a scanner can distinguish tumor from normal tissue without surgery, biopsy, or ionizing radiation.
What this patent does NOT cover
The boundaries
- The image reconstruction algorithms (Fourier transform methods) that turn NMR signals into 2D or 3D images — developed separately by Lauterbur and Mansfield
- Gradient coils that spatially encode the NMR signal — Lauterbur's key innovation enabling spatial imaging
- Functional MRI (fMRI) — measuring blood oxygenation to detect brain activity
- MRI contrast agents (gadolinium) — injected materials that enhance image contrast
These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.
What made this novel
Damadian was a medical doctor and physicist who in 1971 placed a live rat inside an NMR machine and showed that cancer cells produced different NMR signals than normal cells — specifically, that tumor tissue had longer T1 relaxation times. This was the first evidence that NMR could distinguish tissue types, suggesting a non-invasive cancer detection tool. He published the finding in Science in 1971. The subsequent controversy: Paul Lauterbur independently developed the mathematics of spatial NMR imaging (MRI as we know it — the actual image-forming system) and Peter Mansfield improved the speed and quality of acquisition. In 2003, the Nobel Prize in Physiology or Medicine went to Lauterbur and Mansfield — not Damadian, despite his foundational tissue-discrimination discovery. Damadian protested publicly, taking out full-page ads in major newspapers.
Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.
Where you've seen this
Real-world examples
Damadian built the first whole-body MRI scanner ('Indomitable') in 1977 at his company FONAR — it took 5 hours to produce the first human image
Modern MRI machines operate at 1.5 to 7 Tesla field strength (vs. Damadian's early 0.1 Tesla), producing millimeter-resolution images in seconds
Over 40 million MRI scans are performed annually in the U.S. — it is the primary diagnostic tool for soft tissue injury, neurological disease, and cancer staging
Why it matters
The bigger picture
MRI is the most significant medical imaging advance since X-rays. Unlike CT scans, it uses no ionizing radiation; unlike ultrasound, it produces high-resolution cross-sectional images of any body part. The ability to distinguish tissue types non-invasively revolutionized oncology, neurology, cardiology, and orthopedics. Damadian's foundational patent on tissue discrimination using NMR generated substantial licensing revenue for his company FONAR — GE, Siemens, and other scanner manufacturers paid royalties. The controversy over the Nobel Prize omission remains one of the most discussed in science: did the prize committee deliberately exclude Damadian, or did his tissue-discrimination work not qualify as the key invention of spatial imaging?
Filed
March 17, 1972
Granted
February 5, 1974
Claim 1 — Plain English
What this patent covers
This patent describes a method of using nuclear magnetic resonance (NMR) to detect differences between cancerous and healthy tissue. NMR works by placing tissue in a strong magnetic field and then applying radio frequency pulses. The hydrogen nuclei (protons) in water and fat molecules absorb the radio energy and emit their own signals as they relax back to their baseline state. The key discovery: cancerous tissues have higher water content and different molecular environments than healthy tissues, causing their protons to relax differently — with longer T1 and T2 relaxation times. By measuring these relaxation times, a scanner can distinguish tumor from normal tissue without surgery, biopsy, or ionizing radiation.
The clever bit
Damadian was a medical doctor and physicist who in 1971 placed a live rat inside an NMR machine and showed that cancer cells produced different NMR signals than normal cells — specifically, that tumor tissue had longer T1 relaxation times. This was the first evidence that NMR could distinguish tissue types, suggesting a non-invasive cancer detection tool. He published the finding in Science in 1971. The subsequent controversy: Paul Lauterbur independently developed the mathematics of spatial NMR imaging (MRI as we know it — the actual image-forming system) and Peter Mansfield improved the speed and quality of acquisition. In 2003, the Nobel Prize in Physiology or Medicine went to Lauterbur and Mansfield — not Damadian, despite his foundational tissue-discrimination discovery. Damadian protested publicly, taking out full-page ads in major newspapers.
What it does not cover
- The image reconstruction algorithms (Fourier transform methods) that turn NMR signals into 2D or 3D images — developed separately by Lauterbur and Mansfield
- Gradient coils that spatially encode the NMR signal — Lauterbur's key innovation enabling spatial imaging
- Functional MRI (fMRI) — measuring blood oxygenation to detect brain activity
- MRI contrast agents (gadolinium) — injected materials that enhance image contrast
Patent Journey
From filing to expiry
Patent Filed
1972
Patent Granted
1974 · 2yr after filing
Highly Cited
83 patents cite this
Patent Expired
1992
PatentBrief Score
Impact Score
Moderate
Citation count
38/40
Highly cited
Claim breadth
14/20
Broad claims
Recency
0/20
Older than 20 years
Assignee scale
0/20
Independent or smaller assignee
PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.
The original legal language
Original claims
21 claims as filed with the patent office.
Glossary
Key terms defined
- Tesla
- The unit of magnetic field strength — MRI machines typically operate at 1.5 or 3 Tesla (Earth's magnetic field is 0.00005 Tesla)
- T1/T2 relaxation times
- The characteristic times for NMR signal decay — different in cancerous vs. healthy tissue, enabling tissue discrimination
- nuclear magnetic resonance (NMR)
- The physical phenomenon where atomic nuclei in a magnetic field absorb and re-emit radio frequency energy — the physical basis of MRI
Citations
Patent lineage
Stay in the loop
Get a weekly digest of new patents.
One email per week. No spam. Unsubscribe anytime.
Keep exploring
Related patents you should know
US 12564871 · 2026
A Fixture for Cleaning Showerheads with Multiple Separate Chambers
This patent describes a cleaning device for showerheads that uses a fixture with three or more separate internal compartments and channels to direct cleaning fluid to the showerhead's upper surfaces.
ASM IP HOLDING BV
US 12324579 · 2025
Surgical Stapler Battery Health Check During Operation
This patent describes a powered surgical stapler that can detect if some of its rechargeable battery cells are damaged while it's actually firing staples, helping ensure the procedure finishes safely.
CILAG GMBH INT
US 12471982 · 2025
Surgical Tool That Combines Energy Treatment and Stapling
CILAG's patent details a surgical instrument that applies therapeutic energy to tissue, monitors its properties, then deploys staples, adapting the stapling based on the initial energy treatment and monitoring.
CILAG GMBH INT
US 11918209 · 2024
Real-Time Surgical Instrument Status on Live Video During Operations
This patent describes a surgical system that shows live video from inside the body and overlays important information about the surgical tool directly onto the screen, helping surgeons operate more precisely.
CILAG GMBH INT
US 8697359 · 2014
How to Use CRISPR-Cas9 to Edit Genes in Human Cells
This patent describes a method and system for precisely altering gene expression in eukaryotic cells, including human cells, using an engineered CRISPR-Cas9 system that targets and cleaves specific DNA sequences.
Massachusetts Institute of Technology
US 4683195 · 1987
How to Make Many Copies of a Specific DNA Segment
This patent describes the Polymerase Chain Reaction (PCR), a fundamental process for making millions of copies of a specific DNA or RNA segment from a tiny sample, enabling its detection.
Cetus Corp
Semantically similar
You might also find these interesting
US 2495429 · 1950 · Raytheon Manufacturing Co
The Microwave Oven — Invented When a Radar Engineer Melted a Chocolate Bar
US 4683195 · 1987 · Cetus Corp
How to Make Many Copies of a Specific DNA Segment
US 4736866 · 1988 · Harvard University
OncoMouse — The First Patented Animal, Built to Get Cancer
US 2612994 · 1952
The Barcode — The Lines on Every Product in Every Store
Same assignee
More from Individual
Patent monitoring